Search Within

Michael John Mauro

Formats
  1. Meeting Abstract (188)
  2. Journal Article (67)
  3. Review (8)
  4. Correspondence (4)
  5. Research Letter (3)
  6. Book Section (2)
  7. Editorial (2)
  8. Guidelines (2)
Groups
  1. Adult Leukemia (276)
  2. Center for Hematologic Malignancies (276)
  3. Department of Medicine (276)
  4. Hematologic Malignancies, Division of (276)
  5. Biostatistics Service (10)
  6. Epidemiology and Biostatistics (10)

More Groups

People
  1. Raajit Rampal (12)
  2. Ellin Berman (8)
  3. Eytan Stein (8)
  4. Martin Tallman (7)
  5. Amber King (6)
  6. Andriy Derkach (6)

More People

Years
  1. 2025 (7)
  2. 2024 (17)
  3. 2023 (26)
  4. 2022 (33)
  5. 2021 (21)
  6. 2020 (26)

More Years

Publications
  1. Blood (97)
  2. Clinical Lymphoma, Myeloma and Leukemia (44)
  3. Journal of Clinical Oncology (22)
  4. Haematologica (21)
  5. Leukemia (12)
  6. American Journal of Hematology (8)

More Publications

Publishers
  1. American Society of Hematology (101)
  2. Elsevier Inc. (47)
  3. American Society of Clinical Oncology (22)
  4. Ferrata Storti Foundation (21)
  5. Nature Publishing Group (13)
  6. John Wiley & Sons (8)

More Publishers

Results (276)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cross-intolerance with dasatinib among imatinib-intolerant patients with chronic phase chronic myeloid leukemia
    Journal Article

    Khoury, H. J.; Goldberg, S. L.; Mauro, M. J.; Stone, R. M.; Deininger, M. W.; Bradley-Garelik, M. B.; Mohamed, H.; Guilhot, F.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib
    Journal Article

    Cortes, J. E.; Khoury, H. J.; Kantarjian, H.; Brümmendorf, T. H.; Mauro, M. J.; Matczak, E.; Pavlov, D.; Aguiar, J. M.; Fly, K. D.; Dimitrov, S.; more...
    American Journal of Hematology (2016)

    Fulltext@MSK | Save
  • Efficacy and safety of midostaurin in advanced systemic mastocytosis
    Journal Article

    Gotlib, J.; Kluin-Nelemans, H. C.; George, T. I.; Akin, C.; Sotlar, K.; Hermine, O.; Awan, F. T.; Hexner, E.; Mauro, M. J.; Sternberg, D. W.; more...
    New England Journal of Medicine (2016)

    Fulltext@MSK | Save
  • Evaluating the impact of a switch to nilotinib on imatinib-related chronic low-grade adverse events in patients with CML-CP: The ENRICH study
    Journal Article

    Cortes, J. E.; Lipton, J. H.; Miller, C. B.; Busque, L.; Akard, L. P.; Pinilla-Ibarz, J.; Keir, C.; Warsi, G.; Lin, F. P.; Mauro, M. J.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Unique cutaneous reaction to second- and third-generation tyrosine kinase inhibitors for chronic myeloid leukemia
    Journal Article

    Patel, A. B.; Solomon, A. R.; Mauro, M. J.; Ehst, B. D.
    Dermatology (2016)

    Fulltext@MSK | Save
  • Absolute quantification of BCR-ABL RNA using multiplexed digital RT-PCR
    Meeting Abstract

    Arcila, M. E.; Benayed, R.; Kiecka, I.; Milbury, C.; Mauro, M.; Samuels, M. L.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Rapid achievement of MR(4.5) after switching from imatinib (IM) to nilotinib (NIL) in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP): Preliminary results from ENESTgoal
    Meeting Abstract

    Ritchie, E. K.; Catchatourian, R.; Klisovic, R. B.; Deininger, M. W.; Erba, H. P.; Radich, J. P.; Savona, M. R.; Warsi, G.; Paley, C. S.; Dautaj, I.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Clinical evaluation of Xpert(R) BCR-ABL Ultra, an automated and standardized cartridge-based assay for the quantification of BCR-ABL1
    Meeting Abstract

    Mauro, M. J.; Press, R. D.; Snyder, D. S.; Huang, Q.; Pinilla-Ibarz, J.; Qin, D. H.; Lockwood, C.; Payton, J. E.; Uy, G. L.; Kalaycio, M. E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
    Blood (2015)

    Fulltext@MSK | Save
  • ENESTnext final results: Deep molecular response (MR) with nilotinib (NIL) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP)
    Meeting Abstract

    Berdeja, J. G.; Heinrich, M.; Dakhil, S.; Goldberg, S. L.; Wadleigh, M.; Catchatourian, R.; Kuriakose, P.; Cortes, J. E.; Radich, J. P.; Rizzieri, D. A.; more...
    Blood (2015)

    Fulltext@MSK | Save